NO126865B - - Google Patents
Download PDFInfo
- Publication number
- NO126865B NO126865B NO00595/71A NO59571A NO126865B NO 126865 B NO126865 B NO 126865B NO 00595/71 A NO00595/71 A NO 00595/71A NO 59571 A NO59571 A NO 59571A NO 126865 B NO126865 B NO 126865B
- Authority
- NO
- Norway
- Prior art keywords
- acid
- acyl
- general formula
- group
- methyl
- Prior art date
Links
- 239000002253 acid Substances 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- -1 benzyl ester Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 231100000086 high toxicity Toxicity 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 229960002895 phenylbutazone Drugs 0.000 description 2
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical group CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- RPAGTNHFINKHKB-UHFFFAOYSA-N 2-(1-acetyl-5-methoxy-2-methylindol-3-yl)acetic acid Chemical compound COC1=CC=C2N(C(C)=O)C(C)=C(CC(O)=O)C2=C1 RPAGTNHFINKHKB-UHFFFAOYSA-N 0.000 description 1
- CALFHRIISWZGPN-UHFFFAOYSA-N 2-[5-methoxy-2-methyl-1-(4-methylpentanoyl)indol-3-yl]acetic acid Chemical compound CC(CCC(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C)C CALFHRIISWZGPN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- DKHSMDIHYAZFBT-UHFFFAOYSA-N C(C=CC=CC)(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C Chemical compound C(C=CC=CC)(=O)N1C(=C(C2=CC(=CC=C12)OC)CC(=O)O)C DKHSMDIHYAZFBT-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 230000000326 anti-hypercholesterolaemic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229960000649 oxyphenbutazone Drugs 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B19/00—Liquid-phase epitaxial-layer growth
- C30B19/02—Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux
- C30B19/04—Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux the solvent being a component of the crystal composition
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B19/00—Liquid-phase epitaxial-layer growth
- C30B19/06—Reaction chambers; Boats for supporting the melt; Substrate holders
- C30B19/061—Tipping system, e.g. by rotation
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/10—Inorganic compounds or compositions
- C30B29/40—AIIIBV compounds wherein A is B, Al, Ga, In or Tl and B is N, P, As, Sb or Bi
- C30B29/42—Gallium arsenide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydraulic Turbines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP199966 | 1966-01-12 | ||
| JP2730066 | 1966-04-28 | ||
| JP2730166 | 1966-04-28 | ||
| JP2812566 | 1966-05-02 | ||
| JP2840066 | 1966-05-04 | ||
| JP4059166 | 1966-06-21 | ||
| JP4472366 | 1966-07-08 | ||
| JP4472466 | 1966-07-08 | ||
| JP5467566 | 1966-08-19 | ||
| JP5467466 | 1966-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126865B true NO126865B (sl) | 1973-04-02 |
Family
ID=27579471
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00166327A NO126862B (sl) | 1966-01-12 | 1967-01-10 | |
| NO00594/71A NO126864B (sl) | 1966-01-12 | 1971-02-18 | |
| NO00595/71A NO126865B (sl) | 1966-01-12 | 1971-02-18 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00166327A NO126862B (sl) | 1966-01-12 | 1967-01-10 | |
| NO00594/71A NO126864B (sl) | 1966-01-12 | 1971-02-18 |
Country Status (13)
| Country | Link |
|---|---|
| AT (4) | AT277996B (sl) |
| BE (1) | BE692456A (sl) |
| BR (1) | BR6786134D0 (sl) |
| CS (3) | CS155158B2 (sl) |
| DE (2) | DE1620441C3 (sl) |
| DK (1) | DK134715B (sl) |
| FI (1) | FI49162C (sl) |
| FR (1) | FR7844M (sl) |
| IL (1) | IL27173A (sl) |
| NL (1) | NL146804B (sl) |
| NO (3) | NO126862B (sl) |
| SE (2) | SE307795B (sl) |
| SU (1) | SU375847A3 (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU162374B (sl) * | 1969-04-03 | 1973-02-28 | ||
| CZ300116B6 (cs) * | 2006-12-05 | 2009-02-11 | Zentiva, A. S. | Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
-
1966
- 1966-12-28 IL IL27173A patent/IL27173A/en unknown
- 1966-12-30 DE DE1620441A patent/DE1620441C3/de not_active Expired
- 1966-12-30 DE DE19661618933 patent/DE1618933A1/de active Pending
-
1967
- 1967-01-04 AT AT971468A patent/AT277996B/de not_active IP Right Cessation
- 1967-01-04 AT AT971168A patent/AT280991B/de not_active IP Right Cessation
- 1967-01-04 AT AT971368A patent/AT277995B/de not_active IP Right Cessation
- 1967-01-04 AT AT09712/68A patent/AT283349B/de not_active IP Right Cessation
- 1967-01-09 CS CS795569*1A patent/CS155158B2/cs unknown
- 1967-01-09 NL NL676700300A patent/NL146804B/xx unknown
- 1967-01-09 CS CS795469*1A patent/CS155157B2/cs unknown
- 1967-01-09 CS CS20067*#A patent/CS155156B2/cs unknown
- 1967-01-10 DK DK13967AA patent/DK134715B/da unknown
- 1967-01-10 NO NO00166327A patent/NO126862B/no unknown
- 1967-01-11 BE BE692456D patent/BE692456A/xx unknown
- 1967-01-12 SE SE14751/67*A patent/SE307795B/xx unknown
- 1967-01-12 SE SE489/67A patent/SE314985B/xx unknown
- 1967-01-12 BR BR186134/67A patent/BR6786134D0/pt unknown
- 1967-01-12 FI FI670074A patent/FI49162C/fi active
- 1967-01-12 SU SU1126031A patent/SU375847A3/ru active
- 1967-03-14 FR FR98691A patent/FR7844M/fr not_active Expired
-
1971
- 1971-02-18 NO NO00594/71A patent/NO126864B/no unknown
- 1971-02-18 NO NO00595/71A patent/NO126865B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SU375847A3 (sl) | 1973-03-23 |
| IL27173A (en) | 1972-08-30 |
| AT280991B (de) | 1970-05-11 |
| FI49162C (fi) | 1975-04-10 |
| NO126864B (sl) | 1973-04-02 |
| CS155156B2 (sl) | 1974-05-30 |
| BE692456A (sl) | 1967-06-16 |
| AT277996B (de) | 1970-01-12 |
| SE314985B (sl) | 1969-09-22 |
| DE1643506A1 (de) | 1972-03-30 |
| FR7844M (sl) | 1970-06-01 |
| NO126862B (sl) | 1973-04-02 |
| DE1643506B2 (de) | 1973-01-04 |
| BR6786134D0 (pt) | 1973-12-26 |
| DE1620441C3 (de) | 1975-05-22 |
| SE307795B (sl) | 1969-01-20 |
| CS155158B2 (sl) | 1974-05-30 |
| CS155157B2 (sl) | 1974-05-30 |
| AT277995B (de) | 1970-01-12 |
| DE1620441B2 (de) | 1974-09-19 |
| DE1618933A1 (de) | 1972-03-16 |
| AT283349B (de) | 1970-08-10 |
| DK134715C (sl) | 1977-05-31 |
| DE1620441A1 (de) | 1970-08-27 |
| NL6700300A (sl) | 1967-07-13 |
| NL146804B (nl) | 1975-08-15 |
| DK134715B (da) | 1977-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3535344A (en) | 3,4-cis-4-aryl-isoflavanes | |
| US4395423A (en) | Polycyclic cyanoketones | |
| Jurd | Plant Polyphenols. VI. Experiments on the Synthesis of 3, 3'-and 4, 4'-Di-O-Methylellagic Acid1 | |
| NO154346B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater. | |
| Rekka et al. | Synthesis of new azulene derivatives and study of their effect on lipid peroxidation and lipoxygenase activity | |
| US3519652A (en) | Bis-chromonyl compounds | |
| Kaufman | Synthetic Furocoumarins. I. A new synthesis of methyl-substituted psoralenes and isopsoralenes | |
| Sarel et al. | Preparation and Degradation of 3α-Hydroxycholanic Acid | |
| Allen Jr et al. | Behavior of 2-carbomethoxy-and 2-acetyl-1, 4-benzoquinone in the Nenitzescu indole syntheses | |
| Ballantine et al. | 427. The chemistry of bacteria. Part IV. AC 20-acid from violacein | |
| Tomita | The Antibacterial Properties of Compounds Containing the Tricarbonyl-methane Group. V The Syntheses of 3-Acyl-2, 4-dihydroxyquinolines and of the Related Compounds, with respect to their Antibacterial Properties | |
| NO126865B (sl) | ||
| Pan et al. | Derivatives of Fluorene. IX. 4-Hydroxy-2-fluorenamine; New 3, 4-Benzocoumarin Derivatives1 | |
| Wiley et al. | 2-Pyrones. Xvii. Aryl hydrazones of triacetic lactone and their rearrangement to 1-Aryl-3-carboxy-6-methyl-4-pyridazones. The methyl ether of triacetic lactone | |
| Fried et al. | Neogermitrine, a New Ester Alkaloid from Veratrum Viride1 | |
| US2558211A (en) | Preparation of 4-hydroxyquinoline compounds | |
| CA1078395A (en) | Anti-inflammatory 1-oxo-isoindoline derivatives and processes for their preparation | |
| Ohta et al. | The Syntheses and Properties of 5-Thiazones | |
| Speckamp et al. | Dihydroquinolones I: Reactions of substituted 4‐oxo‐1, 2, 3, 4‐tetrahydroquinoline | |
| IL28366A (en) | History of Flaban and their preparation | |
| Merchant et al. | Synthesis of Some β-Phenethylamine Derivatives. I. | |
| Baumgarten et al. | Cinnolines. I. A Synthesis of 3-Nitro-and 3-Aminocinnolines | |
| Toda | Synthesis and Properties of 3-Formyl-1-azaazulan-2-one | |
| Schrecker et al. | Components of Podophyllin. VIII. Study of Intermediates in the Synthesis of Dehydroanhydropicropodophyllin1 | |
| Gaudion et al. | 325. The Friedel–Crafts reaction with 1-acyl-2: 3-dimethylindoles |